Excellent post and a reminder to all that Biotech investing takes a huge amount of personal due-dillegence, a tremendous amount of patience, and a cast-iron stomach. If investors are truly longs, they realize all this and should feel comfortable with their investment. The 40M secured loan CYTR took out for commercial preparation a bit back further convinced me the confidence level is high for they could have simply diluted further.
PPS activity of late is the norm for a biotech company on the cusp of greatness. True longs aren't selling while shorts try taking it down further.Those investors not fully all-in here are getting their stop-losses taken out as the shorts walk this down as we near PH3 results.
I personally have a significant investment here, using profits from a previous Biotech company that's been in Cytr shoes before. Complete with the AF bashing, flash trades, fictitious firms writing negative articles - the whole package prior to its' success. One thing I learned from that experience, is to keep some cash on hand to take advantage of this late-game walk down in the PPS. I truly believe longs will be rewarded.